» Articles » PMID: 32904235

Prediction of Novel Drug-target Complex of Nsp3 of CHIKV Through Molecular Dynamic Simulation

Overview
Journal Heliyon
Specialty Social Sciences
Date 2020 Sep 9
PMID 32904235
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Literature reported that nsp3 of CHIKV is an important target for the designing of drug as it involves in the replication, survival etc. Herein, about eighteen million molecules available in the ZINC database are filtered against nsp3 using RASPD. Top five hit drug molecules were then taken from the total screened molecules (6988) from ZINC database. Then, a one pot-three components reaction is designed to get the pyrazolophthalazine and its formation was studied using DFT method. Authors created a library of 200 compounds using the product obtained in the reaction and filtered against nsp3 of CHIKV based on docking using iGEMDOCK, a computational tool. Authors have studied the best molecules after applying the the Lipinski's rule of five and bioactive score. Further, the authors took the best compound i.e. CMPD178 and performed the MD simulations and tdMD simulations with nsp3 protease using AMBER18. MD trajectories were studied to collect the information about the nsp3 of CHIKV with and without screened compound and then, MM-GBSA calculations were performed to calculate change in binding free energies for the formation of complex. The aim of the work is to find the potential candidate as promising inhibitor against nsp3 of CHIKV.

Citing Articles

Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection.

Sharma K, Subramani C, Ganesh K, Sharma A, Basu B, Balyan S PLoS Pathog. 2025; 20(12):e1012816.

PMID: 39775571 PMC: 11723598. DOI: 10.1371/journal.ppat.1012816.


Peptide aptamer-based time-resolved fluoroimmunoassay for CHIKV diagnosis.

Liu T, Gao C, Wang J, Song J, Chen X, Chen H Virol J. 2023; 20(1):166.

PMID: 37501131 PMC: 10375649. DOI: 10.1186/s12985-023-02132-w.


Exploration of DFT and TD-DFT computation to investigate the interaction between paracetamol and lithium or its compounds.

Singh M, Bhagat P, Jain P, Singh P J Mol Liq. 2023; 383:122114.

PMID: 37223830 PMC: 10191726. DOI: 10.1016/j.molliq.2023.122114.


Growth in chikungunya virus-related research in ASEAN and South Asian countries from 1967 to 2022 following disease emergence: a bibliometric and graphical analysis.

Sofyantoro F, Frediansyah A, Priyono D, Putri W, Septriani N, Wijayanti N Global Health. 2023; 19(1):9.

PMID: 36747262 PMC: 9901127. DOI: 10.1186/s12992-023-00906-z.


Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival.

Cao J, Gong Y, Wu M, Xiong L, Chen S, Huang H Front Cell Infect Microbiol. 2022; 12:1044770.

PMID: 36506032 PMC: 9729774. DOI: 10.3389/fcimb.2022.1044770.


References
1.
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

2.
Das P, Puusepp L, Varghese F, Utt A, Ahola T, Kananovich D . Design and Validation of Novel Chikungunya Virus Protease Inhibitors. Antimicrob Agents Chemother. 2016; 60(12):7382-7395. PMC: 5119020. DOI: 10.1128/AAC.01421-16. View

3.
Pialoux G, Gauzere B, Jaureguiberry S, Strobel M . Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007; 7(5):319-27. DOI: 10.1016/S1473-3099(07)70107-X. View

4.
Yang J, Chen C . GEMDOCK: a generic evolutionary method for molecular docking. Proteins. 2004; 55(2):288-304. DOI: 10.1002/prot.20035. View

5.
Kumar D, Kumari K, Jayaraj A, Singh P . Development of a theoretical model for the inhibition of nsP3 protease of Chikungunya virus using pyranooxazoles. J Biomol Struct Dyn. 2019; 38(10):3018-3034. DOI: 10.1080/07391102.2019.1650830. View